Background: A considerable diversity of prognosis is seen with idiopathic membranous nephropathy (IMN). The initial factors affecting long-term outcome remain unclear. Methods: We studied retrospectively 30 patients with IMN who had been followed up for at least 5 years, or until end-stage renal failure (ESRF). We analyzed the prognostic factors of ESRF in the first renal biopsies; these factors included presence of tubulointerstitial lesions and foam cells, as well as expression of CD68, monocyte chemoattractant protein-1 (MCP-1), its cognate receptor chemokine receptor 2 (CCR2) and ·-smooth muscle actin. Results: The patients who developed ESRF showed higher percentages of glomerular segmental sclerosis, interstitial MCP-1 expression, CCR2-or CD68-positive monocyte/macrophages and foam cells in the interstitium, and these proved on multivariate analysis to be independent risk factors for ESRF. 
Introduction
Human idiopathic membranous nephropathy (IMN) shows considerable heterogeneity with regard to end-stage renal failure (ESRF). 40% of Japanese nephrotic patients, and one third to one half of the patients in other countries, develop ESRF within 20 years of onset, or die from complications. On the other hand, about 25% of patients with IMN undergo spontaneous remission [1] [2] [3] [4] [5] .
We recently reported that the electron microscopic (EM) pattern was an important prognostic factor for ESRF in IMN. We arbitrarily classified IMN patients to two large groups: the homogeneous type with synchronous electron-dense deposits and the heterogeneous type with Yoshimoto/Wada/Furuichi/Sakai/Iwata/ Yokoyama various phases of dense deposits. The heterogeneous group was a risk factor for ESRF, however, many patients with the heterogeneous type did not develop ESRF [6] . Therefore, other factors may be involved in the progression of ESRF in the heterogeneous type of IMN.
In general, interstitial infiltration by mononuclear cells is a characteristic histological finding in progressive renal disease [7] . Mononuclear cells, in particular monocytes and macrophages, are thought to contribute directly, as a source of profibrotic molecules, to interstitial fibrosis. Most of these mononuclear cells are believed to infiltrate into the interstitium from the circulation through peritubular capillaries. Chemoattractant molecules produced by tubular epithelial cells have been conjectured to stimulate and enhance the influx of these cells. Chemokines such as monocyte chemoattractant protein-1 (MCP-1) are considered to play an important role in this step, even in nonproliferative glomerular diseases such as membranous nephropathy [8] . We have also reported previously that locally expressed interstitial MCP-1 participates in the recruitment and activation of macrophages in human diabetic nephropathy [9] . The expression of MCP-1 and its cognate receptor (CCR2) in IMN subtypes of EM findings, and their correlation with the outcomes remain, however, unclear.
In this study, we retrospectively analyzed pathological factors in 30 Japanese patients with IMN who were followed up for at least 5 years after initial renal biopsy. We report here that interstitial CD68-positive cell infiltration, accompanied with MCP-1/CCR2 expression, is a significant indicator of ESRF in human IMN.
Methods

Patients
We retrospectively studied 105 Japanese patients with IMN, who were admitted to the First Department of Internal Medicine of Kanazawa University Hospital, or its affiliated hospitals, between 1965 and 1995. These patients were followed for at least 5 years, or until ESRF or death (from 9 to 330 months, mean 116.1 months) and, among them, 12 patients developed ESRF. We then enrolled 30 background-matched patients of IMN. We selected 10 out of 12 cases of ESRF in whom we could examine more than 10 glomeruli in each initial biopsy specimen. We also selected 20 patients who did not develop ESRF from two groups based on EM findings; 10 patients were the homogeneous type and 10 patients the heterogeneous type by EM study. Diagnosis was confirmed in all patients by percutaneous needle renal biopsy. Informed consent was obtained from all patients. ESRF was defined as the need for hemodialysis, peritoneal dialysis or renal transplantation.
Histopathological Studies
Light Microscopic Examination. For light microscopic examination, renal biopsy specimens were stained with hematoxylin and eosin, periodic acid-Schiff reagent, Mallory-Azan, and periodic acidsilver methenamine, and examined by light microscopy. The frequency of segmental sclerosis (FSGS) was determined. Interstitial infiltration, tubular atrophy and fibrosis in the interstitium were graded as follows: absent (0), faint (0.5), patchy (1), zonal (2) and diffuse (3) .
Renal tissue specimens were examined by two pathologists with no knowledge of the patients' clinical condition to establish the diagnosis by standard pathological method alone.
Electron Microscopic Examination. EM examination procedures were the same as previously described. Specimens were fixed with glutaraldehyde and osmium tetroxide sliced into 0.1-Ìm sections, double-stained with uranyl acetate and lead citrate, and examined under the electron microscope. We modified the classification of Rosen et al. [10] and arbitrarily classified specimens showing synchronous electron-dense deposits with a single phase as the homogeneous type, and others having various phases of electron-dense deposits as the heterogeneous type as we reported [6] .
Immunohistochemical Studies. We analyzed immunohistochemical assays of CD68 (monocyte/macrophage), MCP-1, CCR2 and ·-smooth muscle actin (·-SMA)-positive cells, on formalin-fixed paraffin-embedded tissue sections using a catalyzed signal amplification system (Dako, Kyoto, Japan). The sections were deparaffinized with xylene and ethyl alcohol. Endogenous peroxidase was blocked by immersion in 0.3% H 2 O 2 in 100% methyl alcohol. Endogenous biotin was blocked using a biotin-blocking system (Dako). Sections were washed in Tris buffer saline containing Tween-20 (TBST; 0.05 M Tris-HCl pH 7.6, 0.3 M NaCl and 0.1% Tween-20). Before staining, specimens were treated with target retrieval solution (Dako) at 95°C and then at room temperature. Sections were preincubated with normal goat serum (Vector Laboratories, Burlingame, Calif., USA) diluted 1:200 in TBS, and then incubated with murine anti-human CD68 monoclonal antibody (clone KP1; Dako), murine anti-human ·-SMA monoclonal antibody (clone 1A4; Dako), murine anti-human CCR2 monoclonal antibody (clone 48607.121; R&D Systems, Minneapolis, Minn., USA) and murine anti-human monoclonal MCP-1 antibody (clone 26j2) for 15 min. Peroxidase activities were applied by diaminobenzidine and sections were counterstained with hematoxylin.
In situ Hybridization for MCP-1. In situ hybridization procedures were based on those previously described [9] . These were briefly as follows. A partial sequence of exon 1 (5)-CAGAGACTTT-CATGCTGGAGGCGAGAGTGCGAGCTT-3)) was used for the MCP-1 antisense oligonucleotide probe, and signals were visualized by using digoxigenin-alkaline phosphatase systems (DIG Oligonucleotide Tailing kit and Nucleic Acid Detection kit, Roche Diagnostics, Mannheim, Germany). Formalin-fixed paraffin-embedded tissue sections were deparaffinized using xylene, rehydrated by ethyl alcohol. Sections were digested with 5 Ìg/ml proteinase K (Dako) in TBS for 60 min. Sections were then washed with 2 ! standard saline citrate (SSC; Wako Pure Chemicals, Osaka, Japan). After dehydration, sections were incubated with a hybridization solution containing 100 pmol/ml digoxigenin-labeled MCP-1 oligonucleotide probe. Sections were then washed with 2 ! SSC and maleic acid buffer (Roche Diagnostics). Sections were incubated with maleic acid buffer containing 2% normal sheep serum and 1% blocking reagent. They were then incubated with alkaline phosphatase conjugate anti-digoxi-c27 genin polyclonal antibody. Signals were visualized by incubation with nitroblue tetrazolium (NBT)/5-bromo-4-chloro-3-indolyl phosphatase (BCIP). Negative controls were conducted by replacing the antisense probe with a sense probe for MCP-1, the exact complement of the antisense probe (5)-AAGCTCGCACTCTCGCCTCCAGCA-TGAAAGTCTCTG-3)), and without a probe.
Statistical Analysis
Statistical analyses were performed using the ¯2 test, the ANOVA test, the Kruskal-Wallis test, Pearson and Spearman's correlation coefficient for the analyses of parametric and non-parametric data. The independent risk factors for ESRF outcomes were studied with the Cox proportional hazards model. Values were expressed as mean B SEM. p values of ! 0.05 were considered statistically significant. SAS software was used for the statistical calculations (SAS Institute, Cary, N.C., USA). 
Results
Initial Renal Biopsy Findings Reflect Primary Outcome in the Heterogeneous
Discussion
The prognosis of patients with IMN is variable. We have analyzed the different outcomes of IMN as defined by interstitial and glomerular lesions in this study. We previously reported that EM findings at the first renal biopsy were useful indicators of primary and secondary outcomes in IMN. The homogeneous type with synchronous electron-dense deposits showed favorable long-term primary and secondary outcomes. Though all of the cases who developed ESRF showed the heterogeneous type in EM study, many patients with the heterogeneous type did Yoshimoto/Wada/Furuichi/Sakai/Iwata/ Yokoyama not develop ESRF [6] . Therefore, other factors may be involved in the progression of ESRF in the heterogeneous type of IMN.
The degrees of tubulointerstitial changes and glomerulosclerosis have been reported previously as useful pathological findings for forecasting the outcome of patients with IMN [11] [12] [13] . In the present study, interstitial lesions such as fibrosis, tubular atrophy and interstitial foam cells, and segmental sclerosis were the significant histological predictors of ESRD. In particular, the tubulointerstitial changes were observed in 60% of Japanese patients and had a major impact on outcome in the research carried out as national survey of patients with IMN and nephrotic syndrome by the study group of 'Progressive Renal Disease' supported from the Ministry of Health, Labor and Welfare, Japan [11] . In addition, patients with segmental sclerosis have a significantly lower survival compared to patients without sclerosis [13] . Our results also support these previous reports.
We found, however, that CD68-positive macrophages and foam cells were also significant factors in predicting the outcome of IMN. CD68-positive macrophages can produce proinflammatory and fibrogenic cytokines such as transforming growth factor (TGF)-ß and chemoattractant proteins that are recruited and undergo extensive autostimulation in an autocrine and paracrine manner. MCP-1 produced by tubular epithelial cells and infiltrating macrophages plays a pivotal role in advanced progressive tubulointerstitial damage, and causes impairment of renal function in various human proliferative and nonproliferative renal diseases such as crescentic glomerulonephritis [14] , IgA nephropathy [15] , lupus nephritis [16] , and diabetic nephropathy [9] . Up-regulation of MCP-1 has been reported in Heymann nephritis, an experiment model of membranous nephropathy [17] . This interstitial MCP-1 production may not only be induced by prolonged protein overloading of tubular epithelial cells before biopsy in the heterogeneous type, but may also result from susceptibility based on genetic factors such as polymorphisms in the promoter regions of chemokine genes, as recently reported for MCP-1 in chronic rejection of renal transplants [18] . Further studies may be needed to elucidate the influence of genotype on chemokine-induced interstitial lesions in IMN.
Segerer et al. [19] reported that CCR2 mRNA is expressed by cells in glomeruli and crescents and in infiltrating leukocytes in the tubulointerstitial lesions of crescentic glomerulonephritis, but expression of CCR2, a cognate receptor for MCP-1, in IMN was still uncertain. We have now shown for the first time that CCR2-positive cells infiltrate in advanced human IMN concomitant with MCP-1 expression, and that interstitial CCR2 is an independent risk factor for progression to ESRF. This indicates that CCR2 plays at least one important role in interstitial damage, but not in the causation of glomerular lesions in membranous nephropathy. In general, activated leukocytes and resident cells such as fibroblasts play a critical role in the switch from acute resolution to tissue repair or chronic persistent inflammation [20] . In contrast, patients with minimal change of nephrotic syndrome with massive proteinuria showed undetectable levels of urinary MCP-1, as in healthy volunteers [14, 16] . In patients with progressive IMN, some additional factors such as an inadequate negative feedback system or different genetic backgrounds affecting chemokine production may therefore be responsible for the continuous up-regulation of MCP-1/CCR2 [21] .
We have demonstrated that CD68-positive foam cells in the interstitium expressed MCP-1 strongly in the initial renal biopsies of the heterogeneous type with ESRF. Macrophages are thought to transform into foam cells by digesting modified low-density lipoprotein via scavenger receptors. Foam cells play a significant role in atherosclerosis. Interstitial foam cells are highly represented in nephrotic syndrome and heredity nephropathies such as Alport syndrome [22] , but their exact roles in renal diseases remain unclear. Kurihara et al. [23] reported that 51 out of 320 Japanese patients with IMN were positive for interstitial foam cells that had undergone localized phenotypic transformation, displaying mature macrophage characteristics such as expression of 25F5 antigen and intercellular adhesion molecule-1. Our findings suggest that foam cells may induce prolonged interstitial inflammation and fibrosis by acting as local sources of chemoattractants such as MCP-1, although this hypothesis requires further investigation. The renal interstitial fibrogenic cascade would then progress step by step to the fibrogenic signaling phase, fibrogenic phase and the final phase of renal destruction through chronic persistent inflammation.
·-SMA is a marker of myofibroblasts, that are characterized as intermediate in features between smooth muscle cells and fibroblasts, though the definition is not clear. Myofibroblasts may exist on the downstream of the cytokine/chemokine cascade of renal injury, since fibrogenic cytokines producing by infiltrating macrophages, such as TGF-ß and platelet-derived growth factor, can induce myofibroblasts. ·-SMA-positive cells contribute to interstitial fibrosis by extracellular matrix production [24] , then ·-SMA-positive cellularity diminishes when fibrosis c33 becomes more established [25] , suggesting that ·-SMApositive cells exist downstream of inflammation but upstream of advanced fibrosis. Although there have been several reports of mesangial expression of ·-SMA in IgA nephropathy [26] , we detected ·-SMA-positive cells, mainly around the periglomerular fibrotic lesions, but not in glomeruli. These findings indicate that ·-SMA can function as a predictor and monitor of tubulointerstitial injury, especially interstitial fibrosis, but it might not play a primary role in glomerular lesions in human IMN.
Finally, our results show that the cytokine/chemokine cascade may play a crucial role in the progression of human IMN, suggesting that appropriate inhibition of this cascade may be of benefit. In this respect, we have reported that anti-chemokine treatments, such as anti-MCP-1 antibody [27] and FR167653 [28, 29] , ameliorate chronic renal fibrosis in experimental nephritis models.
Hence, anti-chemokine therapy may prove useful in the treatment of human IMN.
In summary, interstitial MCP-1 and positive CD68 or CCR2 cell infiltration as well as FSGS in the first renal biopsy were useful indicators of primary and secondary outcomes in IMN. Our results also suggest that anti-chemokine therapy may be of use in the treatment of progressive membranous nephropathy, although prospective trials will be required to confirm this idea.
